Knockdown of FLOT1 has been shown to significantly impair cell proliferation and tumourigenicity of breast and esophageal squamous cell carcinoma cells in vitro and in vivo through the Akt/FOXO3a pathways46, 47. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.